AVTX Price / Book | AVALO THERAPEUTICS, INC.

AVALO THERAPEUTICS, INC. (AVTX) Price / Book

2026-09-03: Price/Book Ratio 2.27.
2026-06-30: Price/Book Ratio 2.18.
2026-03-31: Price/Book Ratio 5.38.
2025-12-31: Price/Book Ratio 4.05.

Historical market capitalization divided by filed shareholder equity.

Available history: 2015-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	2.27
2026-06-30	2.18
2026-03-31	5.38
2025-12-31	4.05
2025-09-30	2.48
2025-06-30	0.52
2025-03-31	0.71
2024-12-31	0.58
2024-09-30	4.36
2023-12-31	1
2023-09-30	380.18
2022-03-31	37,135.65
2021-12-31	1,993.76
2021-09-30	17,494.26
2021-06-30	41,883.17
2021-03-31	23,375
2020-12-31	23,217.63
2020-09-30	12,724.48
2020-06-30	11,088.84
2020-03-31	16,625.1
2019-12-31	32,815.07
2019-09-30	22,935.87
2019-06-30	37,979.52
2019-03-31	31,101.46
2018-12-31	18,154.84
2018-09-30	28,046.31
2018-06-30	21,975.51
2018-03-31	15,786.57
2017-12-31	10,343.17
2017-09-30	2,883.42
2017-06-30	7,428.78
2016-12-31	115,505.58
2016-09-30	188,397.99
2016-06-30	9,838.01
2016-03-31	10,463.13
2015-12-31	6,378.65

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
GERON CORP (GERN)	United States	$0.803B	-12.14
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25